Literature DB >> 1695776

Pathology of benign prostatic hyperplasia. Insight into etiology.

J McNeal1.   

Abstract

Morphometric studies of prostates with benign hyperplasia (BPH) have revealed features that may help clarify the disease's natural history and biologic behavior. Hyperplasia arises within a small anatomic region having precise boundaries and containing an unusual juxtaposition of glandular and stromal elements. Diffuse non-nodular enlargement of the transition zone is the commonest morphologic feature of BPH, but nodules show a greater potential for growth and comprise most of the tissue in large (more than 50-gm) resection specimens. Most nodules are predominantly glandular, with features that suggest a pathogenetic role of induction of embryonic-type stroma.

Entities:  

Mesh:

Year:  1990        PMID: 1695776

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  50 in total

1.  A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.

Authors:  Wendy W Barclay; Ralph D Woodruff; M Craig Hall; Scott D Cramer
Journal:  Endocrinology       Date:  2004-10-07       Impact factor: 4.736

2.  The picture of the prostatic lymphokine network is becoming increasingly complex.

Authors:  Georg E Steiner; Bob Djavan; Gero Kramer; Alessandra Handisurya; Martin Newman; Chung Lee; Michael Marberger
Journal:  Rev Urol       Date:  2002

3.  Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.

Authors:  Hongjuan Zhao; Cristiane F Ramos; James D Brooks; Donna M Peehl
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

Review 4.  Incontinence in the elderly, 'normal' ageing, or unaddressed pathology?

Authors:  William Gibson; Adrian Wagg
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

5.  Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

Authors:  Rui Yang; Yu-Xia Ma; Lin-Feng Chen; Ying Zhou; Zhan-Po Yang; Yan Zhu; Xiao-Ling Du; Jian-Dang Shi; Hong-Shun Ma; Ju Zhang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

Review 6.  Hedgehog signaling in prostate growth and benign prostate hyperplasia.

Authors:  Chad M Vezina; And Wade Bushman
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 7.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 8.  A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.

Authors:  Gerald R Cunha; William A Ricke
Journal:  Differentiation       Date:  2011-06-30       Impact factor: 3.880

9.  The accumulation of versican in the nodules of benign prostatic hyperplasia.

Authors:  Lawrence D True; Sarah Hawley; Thomas H Norwood; Kathleen R Braun; Stephen P Evanko; Christina K Chan; Richard C LeBaron; Thomas N Wight
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

10.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.